Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) With Atomoxetine in Young Adults and Its Effects on Functional Outcomes
Clinical trial NCT00510276 · COMPLETED
Trial details
- NCT number
- NCT00510276
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2009-02-01
- Enrollment
- 445
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.